Signed an MOU with Seongnam City on November 12... Providing end-to-end support from prototype development through clinical validation and regulatory approval

Seongnam Mayor Shin Sangjin (third from left) and Jeon Youngtae, chairman of the Korea AI Medical Healthcare Research Institute (fourth from left), pose for a commemorative photo with attendees after signing an agreement to establish a technology integration center for Physical AI-based medical robots in Conference Room 1 at Seongnam City Hall on the 12th.

Seongnam Mayor Shin Sangjin (third from left) and Jeon Youngtae, chairman of the Korea AI Medical Healthcare Research Institute (fourth from left), pose for a commemorative photo with attendees after signing an agreement to establish a technology integration center for Physical AI-based medical robots in Conference Room 1 at Seongnam City Hall on the 12th.

View original image

The Korea Institute for AI Medical Healthcare Research (Chairman Jeon Youngtae; hereinafter, the Institute) announced that it signed a memorandum of understanding (MOU) with Seongnam City (Mayor Shin Sangjin) on November 12 in Conference Room 1 at Seongnam City Hall to successfully carry out the “Physical AI-Based Medical Robot Technology Integration Center Project.”


Attendees at the signing ceremony included Seongnam Mayor Shin Sangjin; Institute Chairman Jeon Youngtae and Vice President Heo Donghyuk; and Lee Juyeon, head of the Seongnam Industry Promotion Agency, along with other key officials. They pledged close cooperation to foster the medical robotics industry.


The project was selected in June for the Ministry of Trade, Industry and Energy’s “2026 Open Ecosystem Development Promotion Project for the Bio Industry.” A total project budget of 24 billion won will be invested over five years, from 2026 to 2030.


Physical AI has particularly significant potential in advanced medical fields where precision is directly tied to patient safety, including surgery, rehabilitation, nursing and diagnostic assistance.


As the global medical market faces deepening population aging and shortages of medical personnel, demand for intelligent medical robots is rising sharply. These include precision surgical robots, wearable rehabilitation robots, and robots that assist with nursing and logistics in hospitals.


However, due to the stringent regulations specific to medical robots, complex clinical validation and approval procedures, even companies with strong technological capabilities have faced high barriers to entry at the commercialization stage.


To address this, the Institute will establish a Physical AI-Based Medical Robot Technology Integration Center, with Seongnam City as its base, and launch an end-to-end technology support system to resolve bottlenecks faced by companies.


The project will be carried out by a consortium of six institutions led by the Institute, the lead research and development organization. The other consortium members are the Seongnam Industry Promotion Agency, Bundang Seoul National University Hospital, CHA Bundang Medical Center, Korea Testing Laboratory, and Konyang University’s Industry-Academic Cooperation Foundation.


Under the agreement, Seongnam City will provide financial and administrative support to ensure the project is firmly established, while the Institute will build the center’s infrastructure and support companies in accordance with the approved project plan.


The two organizations also plan to work together to ensure transparent disbursement and settlement of project funds and to manage project outcomes.


They also plan to expand cooperation to develop the local biohealth industry, including by linking the project with the Seongnam Biohealth Advanced Cluster, which Seongnam City is developing in the Jeongja-dong area of Bundang-gu.



Jeon Youngtae, chairman of the Korea Institute for AI Medical Healthcare Research, said, “By bringing together Seongnam City’s full administrative and financial support and the expertise of the consortium members, we will establish the Technology Integration Center as a hub for medical robotics innovation in Korea. We will ensure that domestic medical robot companies can grow without interruption, from the prototype development stage through clinical validation and entry into global markets.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing